Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pyrithiamine is a thiamine antagonist that inhibits the metabolism of thiamine (vitamin B₁) by acting as a competitive inhibitor of thiamine pyrophosphokinase, the enzyme responsible for converting thiamine to its active form, thiamine pyrophosphate[5][9]. It is not used therapeutically but is employed in research to experimentally induce thiamine deficiency in animal models, thereby studying the physiological effects of thiamine deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pyrithiamine.